Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
This grant opportunity supports clinical trials for rare neurodegenerative diseases that currently lack adequate treatment options. The trials should focus on assessing the safety and effectiveness of medical products to either introduce a new usage or modify existing labeling. The FDA encourages using innovative trial designs to speed up drug development.
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers